Please login to the form below

Not currently logged in
Email:
Password:

cancer control

This page shows the latest cancer control news and features for those working in and with pharma, biotech and healthcare.

MHRA authorises Mirati Therapeutics’ Krazati for non-small cell lung cancer

MHRA authorises Mirati Therapeutics’ Krazati for non-small cell lung cancer

In the UK, over 43, 000 people are diagnosed with lung cancer every year. ... with advanced solid tumours harbouring the KRAS G12C mutation, which causes cancer cells to grow out of control.

Latest news

More from news
Approximately 2 fully matching, plus 31 partially matching documents found.

Latest Intelligence

  • The impact of prostate cancer on global health The impact of prostate cancer on global health

    in enhanced DNA damage and anti-tumour activity in non-HRRm prostate cancer models. ... NC: Historically in the treatment of mCRPC, hormonal therapy has been used to control prostate cancer growth, with chemotherapy also.

  • Avoiding data pitfalls in clinical research Avoiding data pitfalls in clinical research

    In a recent pilot study with Roche Pharmaceutical for a rare cancer indication, Medidata’s Synthetic Control Arm (SCA) pulled actual data from past studies to create well-matched control arms. ... The pilot was successful enough to be accepted for

  • Digital disruption Digital disruption

    Combining ‘drag and drop’ computer simulations they’re trying to predict the best way to kill cancer cells with drugs that control their function. ... Next, they draw in the basic signalling pathways that can go wrong in cancer cells.

  • Winning the war against cancer Winning the war against cancer

    At a regional cancer control meeting in Riga last month the Czech Republic, Slovenia and The Netherlands were held up as examples to learn from in areas such as centralised registries, ... work carried out by the likes of the OECD with its Health at a

  • It’s time for pharma companies to become household names It’s time for pharma companies to become household names

    Pharma helps people survive heart attacks, beat cancer, manage depression and control diabetes, but until the companies behind these medicines become a visible part of people's lives, they're never

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...